125 related articles for article (PubMed ID: 9054515)
1. Modulation of the specificity and activity of a cellular promoter in an adenoviral vector.
Shi Q; Wang Y; Worton R
Hum Gene Ther; 1997 Mar; 8(4):403-10. PubMed ID: 9054515
[TBL] [Abstract][Full Text] [Related]
2. Heart-specific targeting of beta-galactosidase by the ventricle-specific cardiac myosin light chain 2 promoter using adenovirus vectors.
Griscelli F; Gilardi-Hebenstreit P; Hanania N; Franz WM; Opolon P; Perricaudet M; Ragot T
Hum Gene Ther; 1998 Sep; 9(13):1919-28. PubMed ID: 9741430
[TBL] [Abstract][Full Text] [Related]
3. Adenoviral-mediated skeletal muscle transcriptional targeting using chimeric tissue-specific promoters.
Frauli M; Ribault S; Neuville P; Augé F; Calenda V
Med Sci Monit; 2003 Feb; 9(2):BR78-84. PubMed ID: 12601283
[TBL] [Abstract][Full Text] [Related]
4. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
[TBL] [Abstract][Full Text] [Related]
5. Superior tissue-specific expression from tyrosinase and prostate-specific antigen promoters/enhancers in helper-dependent compared with first-generation adenoviral vectors.
Shi CX; Hitt M; Ng P; Graham FL
Hum Gene Ther; 2002 Jan; 13(2):211-24. PubMed ID: 11812278
[TBL] [Abstract][Full Text] [Related]
6. Analysis of tissue-specific gene delivery by recombinant adenoviruses containing cardiac-specific promoters.
Franz WM; Rothmann T; Frey N; Katus HA
Cardiovasc Res; 1997 Sep; 35(3):560-6. PubMed ID: 9415302
[TBL] [Abstract][Full Text] [Related]
7. Encapsidated adenovirus minichromosomes allow delivery and expression of a 14 kb dystrophin cDNA to muscle cells.
Kumar-Singh R; Chamberlain JS
Hum Mol Genet; 1996 Jul; 5(7):913-21. PubMed ID: 8817325
[TBL] [Abstract][Full Text] [Related]
8. Myosin regulatory elements as vectors for gene transfer by intramuscular injection.
Skarli M; Kiri A; Vrbova G; Lee CA; Goldspink G
Gene Ther; 1998 Apr; 5(4):514-20. PubMed ID: 9614576
[TBL] [Abstract][Full Text] [Related]
9. Specific targeting of pancreatic islet cells in vivo by insulin-promoter-driven adenoviral conjugated reporter genes.
Wang X; Olmsted-Davis E; Davis A; Liu S; Li Z; Yang J; Brunicardi FC
World J Surg; 2006 Aug; 30(8):1543-52. PubMed ID: 16855800
[TBL] [Abstract][Full Text] [Related]
10. A convenient plasmid system for construction of helper-dependent adenoviral vectors and its application for analysis of the breast-cancer-specific mammaglobin promoter.
Shi CX; Graham FL; Hitt MM
J Gene Med; 2006 Apr; 8(4):442-51. PubMed ID: 16389604
[TBL] [Abstract][Full Text] [Related]
11. Effects of the Ad5 upstream E1 region and gene products on heterologous promoters.
Hoffmann D; Jogler C; Wildner O
J Gene Med; 2005 Oct; 7(10):1356-66. PubMed ID: 15945123
[TBL] [Abstract][Full Text] [Related]
12. Intraocular adenoviral vector-mediated gene transfer in proliferative retinopathies.
Mori K; Gehlbach P; Ando A; Wahlin K; Gunther V; McVey D; Wei L; Campochiaro PA
Invest Ophthalmol Vis Sci; 2002 May; 43(5):1610-5. PubMed ID: 11980881
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo hepatoma cell-specific expression of a gene transferred with an adenoviral vector.
Arbuthnot PB; Bralet MP; Le Jossic C; Dedieu JF; Perricaudet M; Bréchot C; Ferry N
Hum Gene Ther; 1996 Aug; 7(13):1503-14. PubMed ID: 8864751
[TBL] [Abstract][Full Text] [Related]
14. LacZ gene transfer to skeletal muscle using a replication-defective herpes simplex virus type 1 mutant vector.
Huard J; Akkaraju G; Watkins SC; Pike-Cavalcoli M; Glorioso JC
Hum Gene Ther; 1997 Mar; 8(4):439-52. PubMed ID: 9054519
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of replication-defective adenovirus-vectored vaccines: protection following intramuscular injection is linked to promoter efficiency in muscle representative cells.
Ambriović A; Adam M; Monteil M; Paulin D; Eloit M
Virology; 1997 Nov; 238(2):327-35. PubMed ID: 9400605
[TBL] [Abstract][Full Text] [Related]
16. Activator effect of coinjected enhancers on the muscle-specific expression of promoters in zebrafish embryos.
Müller F; Williams DW; Kobolák J; Gauvry L; Goldspink G; Orbán L; Maclean N
Mol Reprod Dev; 1997 Aug; 47(4):404-12. PubMed ID: 9211424
[TBL] [Abstract][Full Text] [Related]
17. Chimeric smooth muscle-specific enhancer/promoters: valuable tools for adenovirus-mediated cardiovascular gene therapy.
Ribault S; Neuville P; Méchine-Neuville A; Augé F; Parlakian A; Gabbiani G; Paulin D; Calenda V
Circ Res; 2001 Mar; 88(5):468-75. PubMed ID: 11249869
[TBL] [Abstract][Full Text] [Related]
18. The use of the L-plastin promoter for adenoviral-mediated, tumor-specific gene expression in ovarian and bladder cancer cell lines.
Peng XY; Won JH; Rutherford T; Fujii T; Zelterman D; Pizzorno G; Sapi E; Leavitt J; Kacinski B; Crystal R; Schwartz P; Deisseroth A
Cancer Res; 2001 Jun; 61(11):4405-13. PubMed ID: 11389068
[TBL] [Abstract][Full Text] [Related]
19. Analysis of muscle creatine kinase regulatory elements in recombinant adenoviral vectors.
Hauser MA; Robinson A; Hartigan-O'Connor D; Williams-Gregory DA; Buskin JN; Apone S; Kirk CJ; Hardy S; Hauschka SD; Chamberlain JS
Mol Ther; 2000 Jul; 2(1):16-25. PubMed ID: 10899824
[TBL] [Abstract][Full Text] [Related]
20. Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression.
Qin L; Ding Y; Pahud DR; Chang E; Imperiale MJ; Bromberg JS
Hum Gene Ther; 1997 Nov; 8(17):2019-29. PubMed ID: 9414251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
